Dexcom’s Investor Day gave the clearest public preview yet of G8 CGM. From launch timing and 15-day wear to a smaller sensor and future ketone sensing, here’s what users need to know.
Insulet has upgraded its 2026 revenue forecast after a strong start to the year, driven by global demand for Omnipod systems.
An in-depth report on the effects of conflict in the region and what this could mean for diabetes technology and insulin supply across the Middle East and Europe.
Insulet recalls small proportion of its Omnipod 5 insulin patch pump pods after identifying a manufacturing issue that could lead to under-delivery of insulin.
FreeStyle Libre news in March 2026 centres on a key change for UK prescriptions and several international developments.
Tandem Mobi insulin pump launches on Android in the US but despite CE mark has yet to be available in Europe.
CamDiab’s automated insulin delivery technology gets regulatory progress toward fully closed-loop system.
A global survey by Roche of more than 4,300 people with diabetes has highlighted the daily planning, uncertainty and mental effort involved in managing the condition.
News from Portal Diabetes that new medtech for an implantable insulin pump has reached an early regulatory milestone in the US.
After gaining a CE mark in January, the rollout of Eversense 365 implantable sensor, designed to last for a full year is expected in 2026.
Medtronic officially spins off diabetes business to become standalone company MiniMed. Includes news of regulatory updates for the MiniMed insulin pump system.
News of Omnipod Discover app to organise insulin and glucose data plus rollout of Omnipod 5 in the Middle East.
